NCT05745701View on ClinicalTrials.gov

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

May 29, 2023

Study Completion Date

May 29, 2023

Conditions

Healthy

Interventions

DRUG

PF-07081532

Oral Tablet

DEVICE

Cyclosporine

Oral Solution

DRUG

Itraconazole

Oral Capsule

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05745701 - A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults | Biotech Hunter | Biotech Hunter